emergency-sign-at-hospital-300x201-7290191A new report card from the Leapfrog Group, a healthcare watchdog, paints an unflattering picture of safety in New York’s hospitals.

Only 14 of its 139 rated hospitals, or 10 percent, received an “A,” ranking New York 43rd among the 50 states and the District of Columbia.

Twenty hospitals scored “B,” 80 scored “C,” 23 scored “D,” and there were two “Fs” – for the state-operated SUNY Downstate Medical Center in Brooklyn, and for the city-owned Flushing Hospital Medical Center in Queens.

The statewide average, which was just above “C,” was virtually unchanged from last spring’s report, with 30 hospitals receiving higher grades, and 29 scoring lower.

Leapfrog is a coalition of major employers and other healthcare payers focused on reducing medical mistakes, which are estimated to kill hundreds of thousands of patients each year, making them a leading cause of death in the United States.

The grades in the group’s semiannual reports on hospital safety are based on 30 measures, including the rates of preventable infections, bedsores, and surgery errors, surveys of patients, and analysis of procedures and policies.

The Healthcare Association of New York State, which represents hospitals statewide, has faulted Leapfrog’s grading system for relying on measures that are not widely accepted as medically valid, and for using some survey results that are not evidence-based or risk-adjusted. In HANYS’ 2013 report card on hospital report cards, Leapfrog received the lowest score of one star.

In a statement, HANYS spokesman Darren Dopp said some of Leapfrog’s measures “skew toward positive self-report and bear little association with required Medicare outcome measures and associated payment penalties.”

“Use of valid, reliable, and evidence-based measures that are aligned with national efforts will enable patients and families to make better decisions about their care,” Dopp said.

In a federal report card on overall quality, released last summer, New York’s hospitals collectively rated 50th.

 

About the Author

Bill Hammond

As the Empire Center’s senior fellow for health policy, Bill Hammond tracks fast-moving developments in New York’s massive health care industry, with a focus on how decisions made in Albany and Washington affect the well-being of patients, providers, taxpayers and the state’s economy.

Read more by Bill Hammond

You may also like

The Attorney General’s MFCU SNAFU

Attorney General Letitia James' latest fight with the Trump administration focuses on New York's Medicaid Fraud Control Unit, a federally funded agency housed in James' office. On T Read More

Healthcare Revelations in the Enacted Budget Financial Plan

The state financial plan published on June 10 disclosed key information about healthcare revenue and spending that lawmakers had not made public when approving the annual budget two weeks before. Read More

Federal Suit Traces Medicaid Fraud to the Top of NYS Government

The Trump administration's latest salvo against Medicaid fraud takes aim at a different kind of target – two high-ranking New York officials along with a major state contractor. A Read More

Healthcare Highlights in the New State Budget

Governor Hochul's focus on affordability seems to have skipped over the healthcare portions of the new state budget. The deal finalized May 27 Read More

Lawmakers Consider Hiking Fees for Filling Prescriptions

UPDATE: The proposal discussed below passed the Assembly Friday evening by an unofficial vote of 133-0. Having previously been approved by the Senate, the bill will head to Governor Hochul's desk for her signature or ve Read More

Budget Deal Reportedly Earmarks $100M for 1199 and Extends MCO Tax

As Governor Hochul and legislative leaders rush to finalize the overdue state budget, outlines of some healthcare-related deals have begun to emerge from the closed-door negotiations. Read More

Albany Wavers on Shutting Down a Medicaid Racket

As Washington threatens to crack down on fraud and abuse in New York's Medicaid program, state legislators are doing their best to demonstrate why federal intervention is needed. A Read More

Getting to the Bottom of the 340B Drug Discount Boondoggle

Some of New York's largest and most prosperous hospitals are reporting rapidly growing amounts of revenue from pharmacy sales – most of it apparently flowing from a controversial drug discount program known as 340B. Read More